1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Kawulka, K.E. Sprules, T. McKay, R.T. Mercier, P. Diaper, C.M. Zuber, P. Vederas, J.C. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C4 H9 N O3 119.119 D-allothreonine D-peptide linking C3 H7 N O2 89.093 y ALANINE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C9 H11 N O2 165.189 D-PHENYLALANINE D-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 43 3385 3395 10.1021/bi0359527 15035610 Structure of subtilisin A, a cyclic antimicrobial peptide from Bacillus subtilis with unusual sulfur to alpha-carbon cross-links: formation and reduction of alpha-thio-alpha-amino acid derivatives 2004 US J.Am.Chem.Soc. JACSAT 0004 0002-7863 125 4726 4727 10.1021/ja029654t Structure of subtilisin A, an antimicrobial peptide from Bacillus subtilis with unusual posttranslational modifications linking cysteine sulfurs to alpha-carbons of phenylalanine and threonine 2003 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M x-ray 1 1.0 3426.917 Subtilisin A 1 nat polymer Antilisterial bacteriocin subtilisin no yes NKGCATCSIGAACLVDGPIPDFEIAGA(2TL)GL(DPN)GLWG NKGCATCSIGAACLVDGPIPDFEIAGATGLFGLWG A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Bacillus sample 1423 Bacillus subtilis JH642 repository Initial release Version format compliance Version format compliance Structure summary 1 0 2004-06-22 1 1 2008-04-29 1 2 2011-07-13 1 3 2011-10-05 RCSB Y RCSB 2003-07-04 REL REL structures with the lowest energy 50 8 3D_15N-separated_NOESY 3D_13C-separated_NOESY 4D_13C/15N-separated_NOESY HNHA 288 K 301 NOE-derived distance constraints and 20 dihedral angle restraints were used to calculate the structures. dynamic annealing 1 lowest energy SubA collection VNMR Delaglio, F., Grzesiek, S., Vuister, G.W., Zhu, G., Pfeifer, J., Bax, A.J.' processing NMRPipe 2.2 Johnson, B.A., Blevins, R.A.J. data analysis NMRView 5.0 Brunger, A.T., Adams, P.D., Clore, G.M., DeLano, W.L., Gros, P., Grosse-Kunstleve, R.W., Jiang, J.S., Kuszewski, J., Nilges, M., Pannu, N.S., Read, R.J., Rice, L.M., Simonson, T., Warren, G.L. structure solution CNS 1.1 Brunger, A.T., Adams, P.D., Clore, G.M., DeLano, W.L., Gros, P., Grosse-Kunstleve, R.W., Jiang, J.S., Kuszewski, J., Nilges, M., Pannu, N.S., Read, R.J., Rice, L.M., Simonson, T., Warren, G.L. refinement CNS 1.1 500 Varian INOVA 800 Varian INOVA ASN 1 n 1 ASN 1 A LYS 2 n 2 LYS 2 A GLY 3 n 3 GLY 3 A CYS 4 n 4 CYS 4 A ALA 5 n 5 ALA 5 A THR 6 n 6 THR 6 A CYS 7 n 7 CYS 7 A SER 8 n 8 SER 8 A ILE 9 n 9 ILE 9 A GLY 10 n 10 GLY 10 A ALA 11 n 11 ALA 11 A ALA 12 n 12 ALA 12 A CYS 13 n 13 CYS 13 A LEU 14 n 14 LEU 14 A VAL 15 n 15 VAL 15 A ASP 16 n 16 ASP 16 A GLY 17 n 17 GLY 17 A PRO 18 n 18 PRO 18 A ILE 19 n 19 ILE 19 A PRO 20 n 20 PRO 20 A ASP 21 n 21 ASP 21 A PHE 22 n 22 PHE 22 A GLU 23 n 23 GLU 23 A ILE 24 n 24 ILE 24 A ALA 25 n 25 ALA 25 A GLY 26 n 26 GLY 26 A ALA 27 n 27 ALA 27 A THR 28 n 28 2TL 28 A GLY 29 n 29 GLY 29 A LEU 30 n 30 LEU 30 A PHE 31 n 31 DPN 31 A GLY 32 n 32 GLY 32 A LEU 33 n 33 LEU 33 A TRP 34 n 34 TRP 34 A GLY 35 n 35 GLY 35 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A A N O ASN GLY 1 35 2.05 2 A A N O ASN GLY 1 35 1.80 3 A A H1 C ASN GLY 1 35 1.50 3 A A N O ASN GLY 1 35 2.07 4 A A H1 C ASN GLY 1 35 1.24 4 A A N O ASN GLY 1 35 2.17 5 A A H1 C ASN GLY 1 35 1.48 5 A A N O ASN GLY 1 35 2.17 6 A A H1 C ASN GLY 1 35 1.39 7 A A H1 C ASN GLY 1 35 1.53 7 A A N O ASN GLY 1 35 2.10 8 A A H1 C ASN GLY 1 35 1.57 8 A A N O ASN GLY 1 35 2.17 1 A CYS 4 -76.59 49.90 1 A CYS 7 -154.78 46.13 1 A ILE 9 -44.57 -71.57 1 A ALA 12 -164.24 89.87 1 A ILE 19 85.98 32.12 1 A ASP 21 77.52 119.02 1 A PHE 22 15.52 56.87 1 A 2TL 28 -45.12 -28.85 2 A LYS 2 -82.70 -81.37 2 A CYS 7 -155.02 65.92 2 A ILE 9 -59.82 102.03 2 A ALA 12 -158.83 88.15 2 A ILE 19 86.01 35.02 2 A ASP 21 78.61 109.58 2 A PHE 22 32.20 55.29 2 A 2TL 28 -54.55 -165.59 2 A DPN 31 -59.42 -19.93 3 A CYS 4 -156.97 26.29 3 A THR 6 -78.23 41.93 3 A CYS 7 174.83 39.62 3 A ILE 9 -52.25 104.52 3 A ALA 12 -160.01 80.08 3 A ILE 19 86.05 37.71 3 A ASP 21 76.13 109.31 3 A PHE 22 31.24 58.00 3 A GLU 23 -93.64 41.08 3 A 2TL 28 -149.15 19.45 4 A CYS 7 -154.89 65.83 4 A ALA 11 -50.84 106.46 4 A ALA 12 -167.13 28.70 4 A ASP 16 -99.17 31.66 4 A ILE 19 86.21 59.82 4 A ASP 21 63.27 117.01 4 A PHE 22 -24.78 80.06 4 A ILE 24 -88.89 -70.76 5 A LYS 2 -83.15 41.51 5 A CYS 4 45.75 26.70 5 A CYS 7 -155.27 49.78 5 A ALA 12 -159.73 57.15 5 A ASP 16 -97.60 30.32 5 A ILE 19 86.03 58.83 5 A PRO 20 -94.19 38.82 5 A ASP 21 48.32 109.19 5 A PHE 22 -14.67 83.09 5 A 2TL 28 -36.56 -41.24 5 A TRP 34 -131.09 -76.93 6 A THR 6 -78.21 49.70 6 A CYS 7 -178.26 44.38 6 A ILE 9 -58.37 -74.86 6 A ALA 11 -54.63 107.33 6 A ALA 12 -163.97 79.28 6 A ILE 19 86.21 43.00 6 A PRO 20 -56.36 -90.34 6 A ASP 21 154.52 82.50 6 A ILE 24 -89.05 -77.70 7 A CYS 4 37.73 -161.80 7 A ALA 5 -69.84 -176.09 7 A CYS 7 -153.52 34.65 7 A ALA 11 -69.26 64.47 7 A ALA 12 -170.59 75.19 7 A ILE 19 85.77 34.45 7 A ASP 21 77.51 113.55 7 A PHE 22 15.97 57.64 7 A 2TL 28 -44.81 -23.35 7 A TRP 34 -107.33 -77.34 8 A CYS 4 45.60 29.32 8 A CYS 7 -154.48 43.81 8 A ALA 11 -81.19 44.62 8 A ALA 12 -173.21 95.11 8 A ILE 19 86.17 33.68 8 A ASP 21 76.39 105.96 8 A PHE 22 29.30 53.60 8 A ILE 24 -89.26 -76.65 8 A 2TL 28 -51.92 -16.43 8 A TRP 34 -130.17 -76.31 Subtilisin A Structure of Subtilisin A 1 N N A 2TL 28 A 2TL 28 HELX_P A GLY 35 A GLY 35 1 1 8 covale 1.333 A ALA 27 A C ALA 27 1_555 A 2TL 28 A N 2TL 28 1_555 covale 1.331 A 2TL 28 A C 2TL 28 1_555 A GLY 29 A N GLY 29 1_555 covale 1.331 A LEU 30 A C LEU 30 1_555 A DPN 31 A N DPN 31 1_555 covale 1.330 A DPN 31 A C DPN 31 1_555 A GLY 32 A N GLY 32 1_555 covale 1.329 A ASN 1 A N ASN 1 1_555 A GLY 35 A C GLY 35 1_555 covale 1.770 A CYS 7 A SG CYS 7 1_555 A 2TL 28 A CA 2TL 28 1_555 covale 1.775 A CYS 13 A SG CYS 13 1_555 A PHE 22 A CA PHE 22 1_555 covale 1.776 A CYS 4 A SG CYS 4 1_555 A DPN 31 A CA DPN 31 1_555 ANTIMICROBIAL PROTEIN thioether bridge, cyclic peptide, bacteriocin, ANTIMICROBIAL PROTEIN SBOA_BACSU UNP 1 9 O07623 NKGCATCSIGAACLVDGPIPDFEIAGATGLFGLWG 9 43 1PXQ 1 35 O07623 A 1 1 35 BINDING SITE FOR RESIDUE DPN A 31 Software 8 A ASN 1 A ASN 1 8 1_555 A CYS 4 A CYS 4 8 1_555 A 2TL 28 A 2TL 28 8 1_555 A GLY 29 A GLY 29 8 1_555 A LEU 30 A LEU 30 8 1_555 A GLY 32 A GLY 32 8 1_555 A LEU 33 A LEU 33 8 1_555 A GLY 35 A GLY 35 8 1_555 1 P 1